Lamictal (Lamotrigine)

Lamotrigine works by blocking voltage‑gated sodium channels on neurons, which stabilizes the neuronal membrane and reduces the release of excitatory neurotransmitters such as glutamate. This dampening of abnormal electrical activity helps control seizures and contributes to mood stabilization in bipolar disorder.

The appropriate dose of Lamictal is individualized and determined by a prescriber based on the patient’s condition, age, renal and hepatic function, and any concomitant medications. Dosage titration is typically gradual to minimize the risk of rash, and the exact regimen should follow the prescribing information.

Lamictal is classified as Pregnancy Category B, indicating that animal studies have not shown risk, but there are limited human data. It should be used during pregnancy only if the potential benefit justifies the potential risk. Lamotrigine does pass into breast milk; breastfeeding decisions should be made in consultation with a healthcare professional.

To request Lamictal, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide. After submission, the sales team will verify trade or institutional credentials, then provide pricing, availability, shipping details and any required import documentation.

Compared with older anticonvulsants such as carbamazepine, lamotrigine has a broader spectrum covering both focal and generalized seizures and a lower risk of enzyme induction. It also offers mood‑stabilizing benefits not seen with many traditional antiepileptics, making it a preferred option for patients with comorbid bipolar disorder.

Lamictal tablets should be stored at ambient temperature, preferably below 25 °C. Keep them in the original container, protect from moisture, and avoid exposure to direct sunlight or excessive heat to maintain product stability.

Lamictal is taken orally, usually as a tablet, with or without food. The prescriber will provide a titration schedule to gradually increase the dose, which helps reduce the risk of skin reactions. Patients should swallow the tablet whole and follow the dosing instructions provided by their healthcare professional.

The most serious risks include severe skin reactions such as Stevens‑Johnson syndrome or toxic epidermal necrolysis, which require immediate discontinuation of the drug. Other rare but serious concerns are blood dyscrasias, hepatic failure, and anaphylaxis. Prompt medical attention is essential if any of these symptoms appear.

Lamictal is contraindicated in patients with a known hypersensitivity to lamotrigine or any of its excipients. It should also be avoided in individuals who have experienced severe rash reactions to lamotrigine previously. Caution is advised for patients with significant hepatic impairment or those taking interacting enzyme‑inducing medications.